Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Pilot Radioembolisation Clinical Trial Assessing Safety and Efficacy in Recurrent Glioma

NCT: NCT07712770 · NOT_YET_RECRUITING

NCT IDNCT07712770
StatusNOT_YET_RECRUITING
Start Date2026-10
Completion2028-11
SponsorOlivia Newton-John Cancer Research Institute (OTHER)
First posted
Last updated

Brief Summary

This study is testing a new way of treating brain tumours using tiny radioactive beads called SIR-Spheres® (90Y-labelled Resin Microspheres). These microspheres are placed into the blood vessels that feed the tumour. The treatment gives off radiation inside the tumour to try to stop it from growing. This type of treatment is called Selective Internal Radiation Therapy (SIRT), Transarterial Radioembolisation (TARE), or radioembolisation. It is already an accepted treatment for patients with liver cancer. In this study, we are testing if this treatment can be done safely in the brain and how well it works.

Frequently Asked Questions

What is Pilot Radioembolisation Clinical Trial Assessing Safety and Efficacy in Recurrent Glioma?

Pilot Radioembolisation Clinical Trial Assessing Safety and Efficacy in Recurrent Glioma is a clinical trial registered under NCT07712770. Current status: NOT_YET_RECRUITING.

What is the status of NCT07712770?

The current status of NCT07712770 (Pilot Radioembolisation Clinical Trial Assessing Safety and Efficacy in Recurrent Glioma) is: NOT_YET_RECRUITING.

When did Pilot Radioembolisation Clinical Trial Assessing Safety and Efficacy in Recurrent Glioma start?

Pilot Radioembolisation Clinical Trial Assessing Safety and Efficacy in Recurrent Glioma started on 2026-10.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.